166 related articles for article (PubMed ID: 37848996)
1. The effect of PD-1/PD-L1 signaling axis on the interaction between CD19
Xie Z; Dai L; He H; Hong D; Tang H; Xu W; Chen Z; Wang H; Li B; Xie C; Wang Y
Adv Rheumatol; 2023 Oct; 63(1):51. PubMed ID: 37848996
[TBL] [Abstract][Full Text] [Related]
2. The role and clinical significance of programmed cell death- ligand 1 expressed on CD19
Jia XY; Zhu QQ; Wang YY; Lu Y; Li ZJ; Li BQ; Tang J; Wang HT; Song CW; Xie CH; Chen LJ
Clin Immunol; 2019 Jan; 198():89-99. PubMed ID: 30502542
[TBL] [Abstract][Full Text] [Related]
3. [The proportion of CD19
Xie Z; Dai L; He H; Hong D; Wang Y; Xu W; Chen Z; Li B; Xie C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):148-157. PubMed ID: 38284256
[TBL] [Abstract][Full Text] [Related]
4. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
5. The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19
Wang Z; Tan F
Scand J Immunol; 2020 Feb; 91(2):e12836. PubMed ID: 31598989
[TBL] [Abstract][Full Text] [Related]
6. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
8. Patients with systemic lupus erythematosus show increased proportions of CD19
Zhu Q; Li Y; Zhang L; Wang M; Chen Z; Shi J; Li J; Li B; Li Z; Wang Y; Xie C
Clin Rheumatol; 2021 Jan; 40(1):151-165. PubMed ID: 32542581
[TBL] [Abstract][Full Text] [Related]
9. BAFFR expression in circulating T follicular helper (CD4
Sagrero-Fabela N; Ortíz-Lazareno PC; Salazar-Camarena DC; Cruz A; Cerpa-Cruz S; Muñoz-Valle JF; Marín-Rosales M; Alvarez-Gómez JA; Palafox-Sánchez CA
Lupus; 2023 Aug; 32(9):1093-1104. PubMed ID: 37460408
[TBL] [Abstract][Full Text] [Related]
10. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
[TBL] [Abstract][Full Text] [Related]
11. PD-1/PD-L1 governed cross-talk of exhausted CD8
Wang K; Zhao J; Feng X; He S; Li J; Sun F; Xu Z; Yang H; Ye J; Cao L; Ye S
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38233074
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Programmed Death 1 and Diminished Programmed Death Ligand 1 Up-Regulation Capacity of Post-Activated Lupus B Cells.
Stefanski AL; Wiedemann A; Reiter K; Hiepe F; Lino AC; Dörner T
Arthritis Rheumatol; 2019 Sep; 71(9):1539-1544. PubMed ID: 30919595
[TBL] [Abstract][Full Text] [Related]
13. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
[TBL] [Abstract][Full Text] [Related]
14. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
15. [Expression and significance of PD-1 on CD4(+); and CD8(+); T cells from the peripheral blood of patients with systemic lupus erythematosus].
Wang Y; Xie C; Sun M; Chai J; Zhou Y; Chen Y; Tang J; Li B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Sep; 29(9):962-5. PubMed ID: 24011159
[TBL] [Abstract][Full Text] [Related]
16. The immunoregulatory axis (programmed death-1/programmed death ligand-1) on CD4+ T cells in lupus nephritis: association with vitamin D and chemokine C-X-C motif ligand 12.
Youssry S; Hussein A; Moaaz M
Microbiol Immunol; 2021 Sep; 65(9):392-399. PubMed ID: 34081342
[TBL] [Abstract][Full Text] [Related]
17. Changes in the expression of T-cell factor-1 in follicular helper T cells reflect the condition of systemic lupus erythematosus patients.
Zeng X; Zheng M; Liu T; Bahabayi A; Kang R; Xu Q; Alimu X; Lu S; Song Y; Liu C
Int Immunopharmacol; 2022 Jul; 108():108877. PubMed ID: 35729844
[TBL] [Abstract][Full Text] [Related]
18. The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides.
Grywalska E; Smarz-Widelska I; Krasowska-Zajac E; Korona-Glowniak I; Zaluska-Patel K; Mielnik M; Podgajna M; Malm A; Rolinski J; Zaluska W
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):133-143. PubMed ID: 28770269
[TBL] [Abstract][Full Text] [Related]
19. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus.
Wang L; Zhao P; Ma L; Shan Y; Jiang Z; Wang J; Jiang Y
J Rheumatol; 2014 Sep; 41(9):1781-92. PubMed ID: 25028374
[TBL] [Abstract][Full Text] [Related]
20. Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus.
Liu MF; Weng CT; Weng MY
J Biomed Biotechnol; 2009; 2009():406136. PubMed ID: 19759858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]